Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Peter Frishauf

Medscape

Bravenly Global offers products formulated by naturopathic doctors aimed at enhancing health and wellness through carefully selected ingredients.

Bravenly Global

MedShr focuses on medical education and physician engagement, providing a platform for case-based learning and professional development for doctors.

MedShr

Medscape Education

Medscape Professional Network

Medscape Medical Affairs

MedscapeLIVE

Medscape édition française

Medscape Português

Medscape UK

Medscape Español

Our Mission:
To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals.

Our Company:
Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students.

All content on Medscape.com and Medscape.org is available for free.

Highland Capital Partners

Researchers reporting in Vancouver at the annual meeting of the American College of Gastroenterology have identified a higher risk of inflammatory bowel disease (IBD) among adults who consumed a diet rich in ultra-processed foods, suggesting another field for inquiry about the potential role of industrial-produced edible food products in IBD.

The study, which was a meta-analysis of four studies, found a 47% greater risk of IBD in adults who consumed high levels of ultra-processed foods, compared with adults in reference groups.

“Our data are also consistent with other observational studies that found increased consumption of junk food, along with reduced intakes of fresh fruit and vegetables, are associated with the development of IBD. Because Americans consume over 60% of their calories in the form of ultra-processed foods, reductions in this level of consumption could meaningfully decrease the incidence of IBD,” wrote authors who were led by Eric Hecht, MD, PhD, MPH, president and executive director of the nonprofit Institute of Etiological Research, Boca Raton, Fla.

With nutrient-stimulated hormone therapies for obesity in phase 3 trials, and activin-receptor inhibitors the next upcoming drug class, highly effective treatments for obesity are on the horizon.

"We are at a watershed [moment] brought on by the recent introduction of highly effective antiobesity medications," said Ania M. Jastreboff, MD, PhD, in a lecture at #ObesityWeek.

Join us for a live discussion that could transform the way you approach metastatic colorectal cancer treatment! Hear from an expert panel on advances in clinical trial data and real-world evidence to gain the knowledge you need to make informed treatment decisions for patients with mCRC.

This livestream is supported by an educational grant from Bayer.

More and more people are using companion robots to boost social connection, mental support, and overall health. The science suggests it’s more than a gimmick.

⏰ Happening today! Set your alarms to join us to hear experts talk about the latest in #mCRC.
#MedEd #ESMO23

➡️ Register to be notified of when we go live: http://ms.spr.ly/60489NYQ4

A recent editorial blamed ultraprocessed foods for the obesity epidemic, but Caroline Apovian, MD, explains why that's not necessarily true.

'On the other hand, we're treating marijuana as if it has no dangers, risks, or problems associated with it. It's a wonder substance that makes you feel better. Well, I don't think that's the right attitude to take toward marijuana either.'

Dr David Fajgenbaum, MD, MBA, MSc is alive thanks to a repurposed drug. Now his dream is to find cures for millions of people from among drugs we already have. #ChasingMyCure Every Cure 📽️ Catch the full interview here: http://ms.spr.ly/60489NJjC

Oncologists who receive money from the pharmaceutical industry appear more likely to prescribe nonrecommended and low-value drugs in some clinical scenarios, according to a recent analysis of fee-for-service Medicare claims.

New research is testing the theory that indulging in morbid curiosity and scary play can help us build psychological resilience, overcome phobias, and deal with genuine scares. 👻

Metric
Company Name	Medscape	Bravenly Global	MedShr
Symbol
MSH ID	COM:MEDSCAPE	COM:BRAVENLYGLOBAL	COM:MEDSHR
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Health, Wellness & Fitness	Nutritional Supplements	Medical Education
Country	US	US	GB
Stage	Venture Round		Seed
Employee Count	501
Website	medscape.com	bravenlyglobal.com	medshr.com
LinkedIn	medscape	braven-global-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	16.10M
Web Traffic Growth	0.09
Valuation
Raised Capital	21M	1.90M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MEDSCAPE

Medscape

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue